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This report describes a rare case of perioperative midazolam hypersensitivity in a patient without any history of 
allergy. A 39-year-old man was admitted for endoscopic pansinus surgery. During transportation to the operating 
room after injecting antibiotic and midazolam intravenously, the patient complained of shortness of breath. At 3 
months after the event, an intradermal sensitivity test for midazolam proved positive indicating the incident was 
caused by midazolam hypersensitivity. (Korean J Anesthesiol 2010; 59: S1-S2)
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    Drug hypersensitivity refers to any noxious, unintended, or 
undesirable reactions to drugs mediated by a specific immune 
system [1,2], and is one of the most serious complications 
during the perioperative period. The incidence of perioperative 
drug hypersensitivity is difficult to estimate, but a report 
published in England claimed an incidence of 1 in 3,500 
between 1988 and 1990 [3]. 
    Perioperative hypersensitivity may be caused by a variety 
of agents including local anesthetics, muscle relaxants, 
opioids, induction drugs, antibiotics, or latex [4,5]. However, 
hypersensitivity to benzodiazepines, particularly midazolam, 
is extremely rare [4,6]. Here, we report a case of perioperative 
midazolam hypersensitivity in a patient without an allergy 
history. 
Case Report
    A 39-year-old man (weight 65 kg; height 168 cm) was 
scheduled to undergo endoscopic pansinus surgery for the 
treatment of chronic sinusitis. With the exception of well-
controlled hypertension, he was in good health, and the 
routine preoperative laboratory tests, chest radiography and 
electrocardiography were normal.
    In the preanesthetic room, after confirming negativity by 
the skin testing, ceftizoxime 1 g was injected intravenously. 
Intravenous midazolam 2 mg was then injected as a 
premedication, and he was transferred to the operating 
room. However, while being moved to an operating bed, he 
complained of dyspnea. Without delay, oxygen was supplied S2 www.ekja.org
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via a facial mask at 5 L/min. Arterial pulse oxygen saturation, 
electrocardiography and noninvasive blood pressure were 
monitored. Blood pressure was 203/105 mmHg and heart rate 
was 110 beats/min, but despite this oxygen supply, his oxygen 
saturation decreased gradually to 90%. To secure an airway 
without resorting to muscle relaxant, propofol 60 mg was 
administered, and manual ventilation with oxygen initiated. 
After confirming loss of consciousness, a laryngeal mask airway 
was inserted. One hour later, the patient recovered and was 
fully awake. The laryngeal mask airway was then removed and 
he was transported from the operating room to a postanesthetic 
room for further care. IgE immunoassays for penicilloyl G and 
penicilloyl V returned normal results. Total IgE was slightly 
elevated at 102 IU/ml (normal range: 0-100 IU/ml). The 
operation was postponed, and he was discharged two days later 
without any sequelae.
    Skin prick and intradermal tests for midazolam and 
ceftizoxime were conducted three months after the event. The 
intradermal test revealed a positive reaction to midazolam. The 
patient was diagnosed as having midazolam hypersensitivity. 
Four months later, the operation was performed uneventfully 
without the use of midazolam. 
Discussion
    This is a rare case report of midazolam hypersensitivity during 
the perioperative period. Although anaphylactoid reactions to 
midazolam have been reported, no serologic or skin tests were 
performed [7]. Furthermore, midazolam has been used safely 
as an anesthetic agents in patients with drug allergy [6,8].
    Almost all drugs used during the perioperative period can 
lead to drug hypersensitivity, though times of onset and 
manifestations can vary. Clinical findings may reveal isolated 
symptoms ranging from minimal changes in blood pressure 
to life-threatening cardiopulmonary collapse. However, if 
drug hypersensitivity occurs as an anaphylaxis, the onset is 
rapid and the results can be potentially life threatening [9]. 
One report on the anaphylactic reactions during anesthesia 
documented that cutaneous symptoms are more frequent in 
non-allergic anaphylaxis, whereas cardiovascular collapse 
and bronchospasm are more frequent in cases of anaphylaxis 
[5]. In the present case, the typical symptoms and signs of 
anaphylactic reactions were not shown; the main symptom 
was respiratory difficulty without cardiovascular collapse or 
cutaneous symptoms. Furthermore, the reaction occurred 
shortly after the injection of antibiotic and midazolam, and thus 
we suspected the drug hypersensitivity. 
    Whereas the initial diagnosis of perioperative anaphylaxis 
relies on history taking and a physical examination, the 
retrospective diagnosis is based on serologic and skin tests 
[6]. Serum tryptase and histamine are helpful indicators of 
anaphylactic reactions. However, in our case, blood sampling 
was delayed and these serologic tests could not be evaluated. 
In vitro skin testing is a method used for the retrospective 
diagnosis of anaphylactic reactions. Generally, skin testing 
should be performed 4-6 weeks after the anaphylactic episode 
due to subsequent depletion of mast cell and basophil-
mediator [6]. In the present case, skin prick and intradermal 
sensitivity tests for ceftizoxime and midazolam were performed 
three months after the event, and the intradermal test to 1 : 10 
midazolam was positive, proving that the episode was caused 
by midazolam hypersensitivity. 
    This case demonstrates that midazolam, which is considered 
safe even in allergic patients, can induce hypersensitivity 
reactions. Accordingly, we advise that this possibility should be 
borne in mind when midazolam is administered. 
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